The effect of Boswellia resin extract on treatment of patients with Parkinson's disease
Phase 3
Completed
- Conditions
- Parkinson disease.Parkinson disease
- Registration Number
- IRCT20170315033086N4
- Lead Sponsor
- Shahid Beheshti University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
In accordance to UPDRS, only pationts in mild and moderate stage will be recruited
No background of parkinson desease in patient’s family. It must be recorded in the primary questionnaire.
The substance consumed in this research make no conflict with prescribed medicines by the physician, and all the patients recruited in this study will receive the same combination of medicines.
BMI between 18 to 25, this parameter is determined by researcher and physician.
No background of peptic ulcer, any surgery of digesting system, or haemorrhage of digesting system
Age between 55 and 85
No severe heart or vascular disease
No kidney or liver disorder
Exclusion Criteria
Acute or severe infectious disease (viral, bacterial) during research
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Pro- and anti-inflammatory factors. Timepoint: At the recruitment day and after intervention. Method of measurement: ELISA assay kit.
- Secondary Outcome Measures
Name Time Method